This partnership addresses protecting the various connected devices in the blood bank ecosystem, from collections through testing and ultimately distribution.
Asimily’s platform combines comprehensive device visibility, vulnerability management, continuous threat monitoring, and streamlined remediation workflows that are optimized for healthcare and life sciences environments like blood centers.
The Asimily platform enables BCA members to:
Monitor all connected devices, including critical blood testing and processing equipment
Reduce their threat surface by mitigating exploitable vulnerabilities
Detect and respond to threats before they impact blood center operations
Automate security operations with healthcare-optimized workflows
Meet stringent compliance requirements and follow FDA guidance
Safeguard sensitive patient data and intellectual property